参考文献/References:
[1].Pieragnoli P,Paoletti Perini A,Ricciardi G,et al.Recurrences in the blanking period and 12-month success rate by continuous cardiac monitoring after cryoablation of paroxysmal and non-paroxysmal atrial fibrillation[J].J Cardiovasc Electrophysiol,2017,28(6):625-633.
[2].Calkins H,Kuck KH,Cappato R,et al.2012 HRS/EHRA/ECAS expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design[J].Europace,2012,14(4):528-606.
[3].黄从新,张澍,黄德嘉,等.心房颤动:目前的认识和治疗的建议-2018[J].中国心脏起搏与心电生理杂志,2018,32(04):315-368.
[4].Piccini JP, Fauchier L. Rhythm control in atrial fibrillation[J]. Lancet,2016,388(10046):829-840.
[5].Jiang H,Lu Z,Lei H,et al.Predictors of early recurrence and delayed cure after segmental pulmonary vein isolation for paroxysmal atrial fibrillation without structural heart disease[J]. J Interv Card Electrophysiol,2006,15(3):157-163.
[6].Eitel C,Piorkowski C,Hindricks G.Clinical relevance and management of early recurrences after catheter ablation of atrial fibrillation[J].Expert Rev Cardiovasc Ther,2011,9(7):849-852.
[7].Lim HS,Schultz C,Dang J,et al.Time course of inflammation, myocardial injury, and prothrombotic response after radiofrequency catheter ablation for atrial fibrillation[J].Circ Arrhythm Electrophysiol,2014,7(1):83-89.
[8].Willems S,Khairy P,Andrade JG,et al.Redefining the blanking period after catheter ablation for paroxysmal atrial fibrillation: insights from the ADVICE (adenosine following pulmonary vein isolation to target dormant conduction elimination) Trial[J]. Circ Arrhythm Electrophysiol,2016 Aug; 9(8).pii: e003909. doi: 10.1161/CIRCEP.115.003909.
[9].Das M,Wynn GJ,Morgan M,et al.Recurrence of atrial tachyarrhythmia during the second month of the blanking period is associated with more extensive pulmonary vein reconnection at repeat electrophysiology study[J].Circ Arrhythm Electrophysiol,2015,8(4):846-852.
[10].Mujovic N,Marinkovic M,Markovic N,et al.Prediction of very late arrhythmia recurrence after radiofrequency catheter ablation of atrial fibrillation: The MB-LATER clinical score[J]. Sci Rep,2017,7:40828.
[11].Xue Y,Wang X,Thapa S,et al.Very early recurrence predicts long-term outcome in patients after atrial fibrillation catheter ablation: a prospective study[J].BMC Cardiovasc Disord,2017,17(1):109.
[12].Themistoclakis S,China P.Early recurrences of atrial tachyarrhythmias after ablation of atrial fibrillation: how long do we have to be blind?[J].JACC Clin Electrophysiol,2017,3(6):577-579.
[13].Alipour P,Azizi Z,Pirbaglou M,et al.Defining blanking period post-pulmonary vein antrum isolation[J].JACC Clin Electrophysiol,2017,3(6):568-576.
[14].Turco P,de Simone A,La Rocca V,et al.Antiarrhythmic drug therapy after radiofrequency catheter ablation in patients with atrial fibrillation[J].Pacing Clin Electrophysiol,2007,30 (Suppl)1:S112.
[15].Kaitani K,Inoue K,Kobori A,et al.Efficacy of antiarrhythmic drugs short-term use after catheter ablation for atrial fibrillation (EAST-AF) trial[J].Eur Heart J,2016,37(7):610-618.
[16].Sohns C,von Gruben V,Sossalla S,et al.Antiarrhythmic drug therapy for maintaining sinus rhythm early after pulmonary vein ablation in patients with symptomatic atrial fibrillation[J].Cardiovasc Ther,2014,32(1):7-12.
[17].Koyama T,Tada H,Sekiguchi Y,et al.Prevention of atrial fibrillation recurrence with corticosteroids after radiofrequency catheter ablation: a randomized controlled trial[J].J Am Coll Cardiol,2010,56(18):1463-1472.
[18].Jaiswal S,Liu XB,Wei QC,et al.Effect of corticosteroids on atrial fibrillation after catheter ablation: a meta-analysis[J].J Zhejiang Univ Sci B,2018,19(1):57-64.
[19].Imazio M,Brucato A,Ferrazzi P,et al.Colchicine reduces postoperative atrial fibrillation: results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) atrial fibrillation substudy[J].Circulation,2011,124(21):2290-2295.
[20].Deftereos S,Giannopoulos G,Kossyvakis C,et al.Colchicine for prevention of early atrial fibrillation recurrence after pulmonary vein isolation: a randomized controlled study[J].J Am Coll Cardiol,2012,60(18):1790-1796.
[21].Deftereos SG,Vrachatis DA,Angelidis C,et al.The role of colchicine in treating postoperative and post-catheter ablation atrial fibrillation[J].Clin Ther,2019,41(1):21-29.
[22].Mihos CG,Salas MJ,Santana O.The pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in cardiovascular disease: a comprehensive review[J].Cardiol Rev, 2010,18(6):298-304.
[23].Mihos CG,Pineda AM,Santana O.Cardiovascular effects of statins, beyond lipid-lowering properties[J].Pharmacol Res,2014,88:12-19.
[24].Suleiman M,Koestler C,Lerman A,et al.Atorvastatin for prevention of atrial fibrillation recurrence following pulmonary vein isolation: a double-blind, placebo controlled randomized trial[J].Heart Rhythm,2012,9(2):172-178.
[25].Yan P,Dong P,Li Z,et al.Statin therapy decreased the recurrence frequency of atrial fibrillation after electrical cardioversion: a meta-analysis[J].Med Sci Monit,2014,20:2753-2758.
[26].Dentali F,Gianni M,Squizzato A,et al.Use of statins and recurrence of atrial fibrillation after catheter ablation or electrical cardioversion. A systematic review and meta-analysis[J].Thromb Haemost,2011,106(2):363-370.
[27].Masuda M,Mizuno H,Enchi Y,et al.Abundant epicardial adipose tissue surrounding the left atrium predicts early rather than late recurrence of atrial fibrillation after catheter ablation[J]. J Interv Card Electrophysiol,2015,44(1):31-37.
[28].Soucek F,Covassin N,Singh P,et al.Effects of atorvastatin (80 mg) therapy on quantity of epicardial adipose tissue in patients undergoing pulmonary vein isolation for atrial fibrillation[J].Am J Cardiol,2015,116(9):1443-1446.
[29].王齐齐.培哚普利干预心房颤动射频消融术后复发的短期及长期随访研究[D].浙江大学,2017.
[30].Cui Y,Ma C,Long D,et al.Effect of valsartan on atrial fibrillation recurrence following pulmonary vein isolation in patients[J].Exp Ther Med,2015,9(2):631-635.
[31].Burashnikov A,Petroski A,Hu D,et al.Atrial-selective inhibition of sodium-channel current by Wenxin Keli is effective in suppressing atrial fibrillation[J].Heart Rhythm,2012 ,9(1):125-131.
[32].匡荣仁,徐燕,洪雷,等.稳心颗粒对心房颤动患者射频消融术后早期复发的影响[J].心脏杂志,2016,28(05):546-548.
[33].吴桂萍,张变花,车晓文.稳心颗粒对阵发心房颤动患者射频消融术后复发的影响[J].中国药物与临床,2018,18(09):1591-1592.
相似文献/References:
[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(5):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]都明辉,施海峰*,佟佳宾,等.心房颤动消融相关性无症状性脑缺血[J].心血管病学进展,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
DU Minghui,SHI Haifeng*,TONG Jiabin,et al.Silent Cerebral Ischemia Related to Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(5):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
[3]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(5):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[4]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in
Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(5):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[5]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular
Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(5):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[6]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(5):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[7]徐小东,综述,杨东辉,等.决奈达隆治疗心房颤动的现状及展望[J].心血管病学进展,2016,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
XU Xiaodong,YANG Donghui.Status and Prospect of Dronedarone in Treating Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(5):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
[8]张莎,储国俊,吴弘.经导管左心耳封堵术的临床应用进展[J].心血管病学进展,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
ZHANG Sha,CHU Guojun,WU Hong.Clinial Application Advances in Left Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
[9]汪俊,杨浩.心房颤动射频消融的术式演变[J].心血管病学进展,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
WANG Jun,YANG Hao.Evolution of Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
[10]赵璐,苏立.心房颤动与离子通道重构研究进展[J].心血管病学进展,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
ZHAO Lu,SU Li.Research Progress of Atrial Fibrillation and Ion Channel Remodeling[J].Advances in Cardiovascular Diseases,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
[11]解忠慧 崔凯军.心房颤动转子标测与消融的研究进展[J].心血管病学进展,2019,(8):1078.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.002]
XIE Zhonghui,CUI Kaijun.Rotors Ablation in Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2019,(5):1078.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.002]
[12]赵海娟 李珂 赵耀 彭玉霞 黄松群 郭志福.成人先天性心脏病合并心房颤动的诊治进展[J].心血管病学进展,2023,(3):216.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.006]
ZHAO Haijuan,LI Ke,ZHAO Yao,et al.Atrial Fibrillation in Congenital Heart Disease[J].Advances in Cardiovascular Diseases,2023,(5):216.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.006]